Madison Avenue Partners, LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001801265
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2025 · 20 positions · Total reported value $1.68B · Top-10 concentration 86.9% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 53.3% · 5 new · 7 cut · 4 exited
Active Share (vs S&P 500): 99.9% · vs QQQ: 99.8% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -9.8% · vs SPY -12.0% · Prev Value $2.32B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +5.6% · vs SPY +3.5% · Latest Value $2.52B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2025 13F filing, Madison Avenue Partners, LP disclosed 20 equity positions with a combined reported value of $1.68B. The filing implies a focused portfolio: its ten largest positions account for 86.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.
The largest disclosed positions as of Q3 2025 were GHC ($289.42M), SNDK ($231.41M), MKL ($161.15M). By sector, the heaviest allocations are Health Care 33.2%, Real Estate 19.2%. Versus the prior quarter, allocation shifted toward Health Care (+4.1pp), Technology (+3.0pp) and away from Materials (-0.7pp), Other (-2.5pp).
Versus the prior quarter, Madison Avenue Partners, LP opened 5 new positions, trimmed 7 and fully exited 4, a turnover rate of 53.3% of positions. The portfolio's overlap with the prior quarter was 59% of names.
The largest new positions opened in Q3 2025 were BTI ($64.96M), NWSA ($44.63M), CTRI ($14.67M).
Of the 4 positions fully exited versus the prior quarter, the largest were SAGE ($55.42M), INVX ($27.62M), MRP ($23.54M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2025)
- BTI BRITISH AMERN TOB PLC · $64.96M
- NWSA NEWS CORP NEW · $44.63M
- CTRI CENTURI HOLDINGS INC · $14.67M
Fully Exited (vs previous quarter)
- SAGE SAGE THERAPEUTICS INC · prev qtr: $55.42M
- INVX INNOVEX INTERNATIONAL INC · prev qtr: $27.62M
- MRP MILLROSE PPTYS INC · prev qtr: $23.54M
- CRGX CARGO THERAPEUTICS INC · prev qtr: $17.28M
- CNNE CANNAE HLDGS INC · prev qtr: $14.06M
- ARVN ARVINAS INC · prev qtr: $3.68M
- PLRX PLIANT THERAPEUTICS INC · prev qtr: $2.59M
- CMCO COLUMBUS MCKINNON CORP N Y · prev qtr: $701.82K
Insider Transactions (Form 4)
Latest Madison Avenue Partners, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Madison Avenue Partners, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 25 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-115122 (status: Approved), registered 2019-04-30
- Regulatory AUM (Form ADV): $3.93B as of 2026-03-02
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
- Website: madisonavenuepartners.com
Portfolio Structure
- 25 positions · $2.32B reported value (Q2 2026)
- Top 10 holdings = 77.1% of reported value
- Largest position: GHC (GRAHAM HLDGS CO) at 12.1%
- Average position size: $92.92M
Sector Tilt
- Health Care 22.3%
- Financials 20.7%
- Real Estate 13.7%
- (classified holdings cover 89% of value)
Quarterly Activity
- Q2 2026: 7 new, 5 added, 8 reduced, 9 exited
- 5 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
245.83K | $289.42M | 17.27% | Hold | |
| 2 |
|
2.06M | $231.41M | 13.81% | Reduce | |
| 3 |
|
84.31K | $161.15M | 9.62% | Hold | |
| 4 |
|
6.46M | $155.84M | 9.30% | Reduce | |
| 5 |
|
2.55M | $145.93M | 8.71% | Add | |
| 6 |
|
1.99M | $145.15M | 8.66% | Reduce | |
| 7 |
|
9.51M | $138.86M | 8.29% | Hold | |
| 8 |
|
2.20M | $76.06M | 4.54% | Add | |
| 9 |
|
1.22M | $64.96M | 3.88% | New | |
| 10 |
|
1.17M | $47.38M | 2.83% | Reduce | |
| 11 |
|
8.01M | $45.12M | 2.69% | Hold | |
| 12 |
|
1.45M | $44.63M | 2.66% | New | |
| 13 |
|
2.71M | $42.84M | 2.56% | Add | |
| 14 |
|
2.83M | $33.19M | 1.98% | Reduce | |
| 15 |
|
3.62M | $28.69M | 1.71% | Add | |
| 16 |
|
693.14K | $14.67M | 0.88% | New | |
| 17 |
|
2.58M | $4.13M | 0.25% | Hold | |
| 18 |
|
31.54K | $3.95M | 0.24% | Reduce | |
| 19 |
|
417.78K | $1.67M | 0.10% | Reduce | |
| 20 |
|
6.15K | $634.58K | 0.04% | Hold | |
FAQ
What did Madison Avenue Partners, LP buy in 2025-Q3?
In its 2025-Q3 13F filing, Madison Avenue Partners, LP reported 20 equity positions worth $1.68B in aggregate; its largest disclosed positions were GHC ($289.42M), SNDK ($231.41M), MKL ($161.15M).
How large is Madison Avenue Partners, LP's portfolio?
Madison Avenue Partners, LP reported $1.68B of long equity holdings across 20 positions as of 2025-Q3. Top-10 holdings account for 86.9% of reported value.
What is Madison Avenue Partners, LP's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.